Developing new methods to analyze single-cell sequencing data for better disease diagnosis.
A statistical framework for disease classification with scRNA-Seq data
This study is working on a new way to analyze tiny bits of genetic information from individual cells to better understand how differences between cells can affect health, helping doctors choose the best treatments for patients with various diseases.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Berkeley NIH-funded |
| Lab location | 1 site (Berkeley, United States) |
| Project ID | NIH-10900462 on NIH RePORTER |
What this research studies
This research aims to create a statistical framework that enhances the analysis of single-cell RNA sequencing (scRNA-Seq) data, which can provide insights into how individual cell variability affects health outcomes. By collecting and analyzing scRNA-Seq data from diverse patient populations, the project seeks to improve the understanding of diseases and aid in selecting appropriate therapies. The methodology will address the current gaps in statistical approaches, making it easier to interpret complex biological data and its implications for patient health.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with conditions that exhibit significant variability at the cellular level, which may benefit from tailored therapeutic strategies.
Not a fit: Patients with stable, well-understood conditions that do not involve significant cellular variability may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate disease diagnoses and personalized treatment options for patients.
How similar studies have performed: Other research has shown promise in using single-cell sequencing data for improving disease understanding, indicating that this approach has potential for significant advancements.
Where this research is happening
Berkeley, United States
- University of California Berkeley — Berkeley, United States (Active)
Researchers
- Principal investigator: Purdom, Elizabeth — University of California Berkeley
- Study coordinator: Purdom, Elizabeth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.